Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$638K Sell
1,763
-135
-7% -$46.2K 0.2% 76
2026
Q1
$668K Buy
1,898
+49
+3% +$17.5K 0.26% 69
2025
Q4
$605K Sell
1,849
-361
-16% -$115K 0.22% 74
2025
Q3
$624K Buy
2,210
+34
+2% +$9.86K 0.24% 74
2025
Q2
$607K Buy
2,176
+28
+1% +$7.93K 0.29% 73
2025
Q1
$669K Buy
2,148
+415
+24% +$123K 0.38% 65
2024
Q4
$452K Buy
1,733
+123
+8% +$36.5K 0.21% 71
2024
Q3
$519K Buy
1,610
+245
+18% +$80.1K 0.27% 71
2024
Q2
$427K Buy
+1,365
New +$401K 0.24% 74
2021
Q3
$86K Buy
400
+3
+0.8% +$690 0.06% 167
2021
Q2
$97K Buy
+397
New +$97.7K 0.06% 170
2020
Q2
Sell
-426
Closed -$86.3K 141
2020
Q1
$86.3K Sell
426
-22,093
-98% -$4.83M 0.08% 159
2019
Q4
$79.2K Buy
+22,519
New +$4.96M 0.07% 182

Other funds holding AMGN

Wealth Quarterback's AMGN Position: Q2 2026 in Review

Wealth Quarterback reduced its Amgen (AMGN) stake by 7.1% in Q2 2026, selling an estimated $46.2K and leaving 1,763 shares worth $638K. The position accounts for 0.2% of the portfolio, ranked #76.

Wealth Quarterback first reported a position in AMGN in Q4 2019 and has held it in 13 quarters since. The position peaked at $669K in Q1 2025. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wealth Quarterback held 1,763 shares of Amgen worth $638K as of Q2 2026.
  • Wealth Quarterback sold 135 Amgen shares in Q2 2026, an estimated $46.2K.
  • Amgen made up 0.2% of Wealth Quarterback's portfolio in Q2 2026, its #76 holding.
  • Wealth Quarterback first reported a position in Amgen in Q4 2019 and has held it in 13 quarters since.
  • Wealth Quarterback's Amgen position peaked at $669K in Q1 2025.
  • 3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.